Search research articles
Contact Us
Filters
Showing results (1-10 of 86) with videos related to
Page
of 9
Sort By:
Breast Cancer Research : BCR
|
May 13, 2010
On the theory of tumor self-seeding: implications for metastasis progression in humans
Julio A Aguirre-Ghiso
Cell Cycle (Georgetown, Tex.)
|
August 25, 2006
The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities
Julio A Aguirre-Ghiso
Oncogene
|
April 24, 2002
Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo
Julio A Aguirre Ghiso
Nature Reviews. Cancer
|
October 25, 2007
Models, mechanisms and clinical evidence for cancer dormancy
Julio A Aguirre-Ghiso
Cancer Research
|
August 25, 2021
Translating the Science of Cancer Dormancy to the Clinic
Julio A Aguirre-Ghiso
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
October 7, 2008
The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?
Heike Allgayer, Julio A Aguirre-Ghiso
Pigment Cell & Melanoma Research
|
October 22, 2009
Dormancy of metastatic melanoma
Liliana Ossowski, Julio A Aguirre-Ghiso
Cancer Research
|
February 5, 2009
Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy
Denis M Schewe, Julio A Aguirre-Ghiso
Proceedings of the National Academy of Sciences of the United States of America
|
July 25, 2008
ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo
Denis M Schewe, Julio A Aguirre-Ghiso
Developmental Cell
|
March 17, 2012
A local view of cancer
Ross L Cagan, Julio A Aguirre-Ghiso
Page
of 9
Search research articles
Search
Showing results (1-10 of 86) with videos related to
Sort By:
Page
of 9
Breast Cancer Research : BCR
|
May 13, 2010
On the theory of tumor self-seeding: implications for metastasis progression in humans
Julio A Aguirre-Ghiso
Cell Cycle (Georgetown, Tex.)
|
August 25, 2006
The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities
Julio A Aguirre-Ghiso
Oncogene
|
April 24, 2002
Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo
Julio A Aguirre Ghiso
Nature Reviews. Cancer
|
October 25, 2007
Models, mechanisms and clinical evidence for cancer dormancy
Julio A Aguirre-Ghiso
Cancer Research
|
August 25, 2021
Translating the Science of Cancer Dormancy to the Clinic
Julio A Aguirre-Ghiso
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
October 7, 2008
The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?
Heike Allgayer, Julio A Aguirre-Ghiso
Pigment Cell & Melanoma Research
|
October 22, 2009
Dormancy of metastatic melanoma
Liliana Ossowski, Julio A Aguirre-Ghiso
Cancer Research
|
February 5, 2009
Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy
Denis M Schewe, Julio A Aguirre-Ghiso
Proceedings of the National Academy of Sciences of the United States of America
|
July 25, 2008
ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo
Denis M Schewe, Julio A Aguirre-Ghiso
Developmental Cell
|
March 17, 2012
A local view of cancer
Ross L Cagan, Julio A Aguirre-Ghiso
Page
of 9